Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolines

Roland L Knight1, Daniel R Allen, Helen L Birch

  • 1UCB Inflammation Discovery, Granta Park, Great Abington, Cambridge CB21 6GS, United Kingdom. roland.knight@ucb-group.com